Steven Cohen Cin Cor Pharma, Inc. Call Options Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CINC
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About CinCor Pharma, Inc.
- Ticker CINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,764,300
- Description
- CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...